CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
-1.14%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$3.36B
AUM Growth
+$3.36B
(-0.1%)
Cap. Flow
+$170M
Cap. Flow
% of AUM
5.07%
Top 10 Holdings %
Top 10 Hldgs %
63.12%
Holding
55
New
4
Increased
15
Reduced
6
Closed
6
Top Buys
| 1 |
Exact Sciences
EXAS
|
$115M |
| 2 |
Fate Therapeutics
FATE
|
$28.9M |
| 3 |
Beam Therapeutics
BEAM
|
$28.7M |
| 4 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$23.3M |
| 5 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$19M |
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
$39.6M |
| 2 |
BNR
Burning Rock Biotech
BNR
|
$28.9M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$25.5M |
| 4 |
Relay Therapeutics
RLAY
|
$15M |
| 5 |
Adverum Biotechnologies
ADVM
|
$14.2M |
Sector Composition
| 1 | Healthcare | 86.11% |
| 2 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVTA
1
DELISTED
Invitae Corporation
NVTA
| $466M | 13.89% | 12,203,669 -94,369 | -0.8% | -$3.61M |
|
|
2
Exact Sciences
EXAS
$8.98B
| $311M | 9.26% | 2,360,186 +875,037 | +59% | +$115M |
|
|
3
Fate Therapeutics
FATE
$120M
| $280M | 8.35% | 3,400,000 +350,000 | +11% | +$28.9M |
|
4
BioLife Solutions
BLFS
$1.2B
| $268M | 7.98% | 7,440,107 | – | – |
|
5
Pacific Biosciences
PACB
$393M
| $167M | 4.96% | 5,000,000 | – | – |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $151M | 4.49% | 1,550,000 | – | – |
|
7
Alnylam Pharmaceuticals
ALNY
$58.5B
| $124M | 3.7% | 880,000 +100,000 | +13% | +$14.1M |
|
8
Twist Bioscience
TWST
$1.63B
| $124M | 3.69% | 1,000,000 | – | – |
|
|
9
Relay Therapeutics
RLAY
$619M
| $117M | 3.48% | 3,375,058 -433,836 | -11% | -$15M |
|
10
Agios Pharmaceuticals
AGIO
$2.19B
| $112M | 3.33% | 2,165,000 -210,000 | -9% | -$10.8M |
|
11
Codexis
CDXS
$246M
| $99.1M | 2.95% | 4,330,000 | – | – |
|
12
Denali Therapeutics
DNLI
$2.23B
| $91.9M | 2.74% | 1,610,000 +300,000 | +23% | +$17.1M |
|
|
DMTK
13
DELISTED
DermTech, Inc. Common Stock
DMTK
| $88.6M | 2.64% | 1,745,000 +375,000 | +27% | +$19M |
|
14
Revolution Medicines
RVMD
$7.1B
| $84.6M | 2.52% | 1,844,535 +210,000 | +13% | +$9.63M |
|
15
CareDx
CDNA
$727M
| $81.3M | 2.42% | 1,193,335 | – | – |
|
|
16
Beam Therapeutics
BEAM
$1.66B
| $65.5M | 1.95% | 818,820 +358,820 | +78% | +$28.7M |
|
|
ONC
17
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $52.2M | 1.56% | 150,000 | – | – |
|
18
Adaptive Biotechnologies
ADPT
$2.01B
| $46.3M | 1.38% | 1,150,000 +436,875 | +61% | +$17.6M |
|
19
Allogene Therapeutics
ALLO
$251M
| $45.9M | 1.37% | 1,300,000 +355,000 | +38% | +$12.5M |
|
20
Generation Bio
GBIO
$40.4M
| $45.9M | 1.37% | 1,611,214 | – | – |
|
21
4D Molecular Therapeutics
FDMT
$288M
| $43.2M | 1.29% | 995,354 +214,799 | +28% | +$9.32M |
|
|
CNST
22
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $42.1M | 1.25% | 1,800,000 +15,000 | +0.8% | +$351K |
|
23
Sarepta Therapeutics
SRPT
$1.78B
| $41M | 1.22% | 550,000 +20,000 | +4% | +$1.49M |
|
24
Dianthus Therapeutics
DNTH
$759M
| $39.6M | 1.18% | 3,346,034 | – | – |
|
|
GBT
25
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $36.7M | 1.09% | 900,000 +90,000 | +11% | +$3.67M |
|